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Abstract
In situations where it is difficult to enroll patients in randomized controlled trials, external
data can improve efficiency and feasibility. In such cases, adaptive trial designs could be used
to decrease enrollment in the control arm of the trial by updating the randomization ratio at
the interim analysis. Updating the randomization ratio requires an estimate of the amount
of information effectively borrowed from external data, which is typically done with a linear
approximation. However, this linear approximation is not always a reliable estimate, which
could potentially lead to sub-optimal randomization ratio updates. In this note, we highlight this
issue through simulations for exponential time-to-event outcomes, because in this simple setting
there is an exact solution available for comparison. We also propose a potential generalization
that could complement the linear approximation in more complex settings, discuss challenges
for this generalization, and recommend best practices for computing and interpreting estimates
of the effective number of events borrowed.
1 Introduction
In situations where it is difficult to enroll patients in randomized controlled trials, such as in rare
diseases, external data can be used to improve efficiency and feasibility. For example, it may be
possible to borrow data from historical trials meeting Pocock’s criteria (Pocock, 1976). In some
circumstances it may also be possible to borrow data derived from real-world sources, such as
electronic health records (Thomas, 2019). We use the term hybrid controlled trials to refer to
randomized controlled trials in which the trial control arm is augmented with external data. There
are several approaches for borrowing data from external comparators, ranging from simple test-
then-pool decision rules to more complex Bayesian methods (Chen et al., 2000; Ibrahim et al., 2000;
Duan et al., 2006; Neuenschwander et al., 2009; Hobbs et al., 2012; Viele et al., 2014; Ibrahim et al.,
2015; van Rosmalen et al., 2017).
Hobbs et al. (2013) proposed an adaptive trial design in which the randomization ratio is
updated at the interim analysis in the absence of strong evidence for outcome heterogeneity between
randomized controls and external comparators. Updating the randomization ratio requires an
estimate of the amount of information effectively borrowed from external data, and Hobbs et al.
(2013) proposed a linear approximation referred to as the effective historical sample size (EHSS)
which has also been used in subsequent work (Chen et al., 2018; Lewis et al., 2019; Wu et al.,
2019; Normington et al., 2020). Based on our simulation results, this linear approximation appears
reasonable in many settings but can have large bias and variance in others, potentially leading to
suboptimal randomization ratio updates.
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In this note, we highlight this issue through simulations for exponential time-to-event outcomes,
because in this simple setting there is an exact solution available for comparison. We also propose a
potential generalization similar to the approach of Morita et al. (2008, 2012) that could complement
the linear approximation of Hobbs et al. (2013) in more complex settings, discuss challenges for
this generalization, and recommend best practices for computing and interpreting estimates of the
effective number of events borrowed.
2 Estimating the amount of external information borrowed
Borrowing data from external data can increase the precision of estimated treatment effects. Let
τˆ2ref be the precision of the log hazard ratio (HR) between the experimental and control arms at
the interim when excluding external data (the reference model) and let τˆ2hyb be the precision at the
interim when including external data (the hybrid model). Also, let nC and nE be the number of
patients randomized to the control and experimental arms, respectively, by the time of the interim
analysis. Hobbs et al. (2013) proposed to approximate the EHSS as
EHSS ≈ (nC + nE)
(
τˆ2hyb
τˆ2ref
− 1
)
. (1)
The approximation in (1) aims to measure the number of additional patients that would need to
be randomized to the control arm in order to achieve the same precision increase obtained by
borrowing from external data.
In what follows, we make two shifts: 1) focusing on the number of events instead of number of
patients, because in time-to-event analyses precision is primarily a function of the number of events,
and 2) generalizing terminology by referring to ‘effective number of external events’, as opposed
to ‘historical trial events’, because borrowing may be possible from real-world as well as historical
trial data.
Focusing on the number of events allows for a more direct development, but randomization ratio
changes are based on the number of patients effectively borrowed. Therefore, we must convert to
the effective external sample size. To do so, we would need to make assumptions about the number
of additional patients required in order to observe the additional number of events. For example,
let κ be the proportion of patients enrolled in the trial control arm who have experienced an event
by the interim analysis. Assuming the additional patients would have been enrolled at the same
rate and over the same amount of enrollment time and study follow-up time as patients in the trial
control arm, we could estimate the effective number of external patients by dividing the effective
number of external events (dˆeff below) by κ, i.e. dˆeff/κ.
2.1 Exact solution for exponential data
Let dC and dE be the number of events in the control and experimental arm, respectively, of the
trial at the interim analysis. For unadjusted exponential models, the precision of the log HR is
(Kalbfleisch and Prentice, 2002)
τˆ2ref =
dCdE
(dC + dE)
. (2)
We denote the estimated number of events effectively borrowed from the external comparator at
the interim analysis as dˆeff. The hybrid model effectively has dC + dˆeff events in the control arm at
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interim. Substituting dC + dˆeff for dC in (2), we get
τˆ2hyb =
(dC + dˆeff)dE
dC + dE + dˆeff
. (3)
Solving (3) for dˆeff, we get
dˆeff =
τˆ2hyb(dC + dE)− dCdE
dE − τˆ2hyb
. (4)
When using unadjusted exponential models to analyze trial data, (4) gives the exact number of
additional events that the trial control arm would have needed by the interim analysis in order to
achieve the same precision as the model that borrows from the external data. This assumes that
the trial analysis is done with an unadjusted model, but allows for arbitrary borrowing models,
including ones with covariate adjustments and/or weighting.
2.2 Generalization to non-exponential models
In unadjusted exponential models, precision is purely a function of the number of events that have
occurred. This makes it straightforward to estimate the effective number of external events. With
other commonly used outcome models, including Cox regression, precision is not solely a function
of the number of events. Consequently, there is not always a unique generalizable solution to dˆeff.
However, it is still possible to define a generalization of (4) that can typically be solved under
certain assumptions. Similar to Morita et al. (2008, 2012) we define the effective number of external
events as
dˆeff := arg min
deff
|τˆ2ref(deff)− τˆ2hyb| (5)
where τˆ2ref(deff) is the hypothetical log HR precision that would have been obtained if deff additional
events had occurred in the control arm via additional trial enrollment and without external data.
We note that (4) is the exact solution to (5) in the case of unadjusted exponential models.
To solve (5), we assume that the additional controls would have had the same distribution of
covariates, enrollment times, and events as the actual trial controls. Under these assumptions,
we can apply a common case weight w to all trial control patients, which effectively multiplies the
number of controls, and thus the number of control arm events, by w. For a given case weight w, the
effective number of control events in the weighted trial dataset is wdC , resulting in dˆeff = wdC −dC
additional events in the control arm.
Because there is a one-to-one mapping between dˆeff and w under these assumptions, we can
attempt to solve (5) numerically by finding the case weight w that leads to a precision equal to
that obtained with the hybrid model. In particular (see Appendix A), we can fit a model to the
observed trial data (excluding external data) and find the common case weight w that when applied
to all control patients results in a precision equal to τˆ2hyb (giving a weight of 1 to all patients in the
experimental arm).
As shown in our simulations, dˆeff estimated according to (5) can have large variability and
bias. However, problematic estimates can be diagnosed by small derivatives of τˆ2ref(deff) prior to
interpreting results. Simulations can help identify a threshold for the derivative prior to analysis,
below which the solution would be ignored.
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3 Simulations
3.1 Exponential data
We simulated interim analysis data for 1:1 randomized trials under four HRs between the experi-
mental and control group. For each HR we simulated 1,000 datasets for a total of 4,000 simulated
datasets. Each simulated trial contained between 60 and 100 total patients enrolled linearly at 2
patients per month. The interim was triggered after 33% of the patients had an event, after which
time all events were censored. For each simulated trial, we also simulated an external comparator
cohort coming from the same distribution as the trial control and restricted follow-up time to the
maximum follow-up in the trial to ensure comparability of endpoints. Please see Appendix B for
details.
For each generated dataset, we fit an exponential model to the trial data excluding external
data (reference model). We also fit an exponential model to the pooled external and trial data
(representing the hybrid model). We used (4) to estimate the number of events in the external
comparator. To facilitate comparison, we used the EHSS approximation in terms of number of
events instead of number of patients, given by
EHSSd ≈ (dC + dE)
(
τˆ2hyb
τˆ2ref
− 1
)
. (6)
Because the external data come from the same generating distribution as the trial controls, the
number of events in the external comparator represents the truth. All models were fit using the
survival package (Therneau, 2015) for R (R Core Team, 2019).
Figure 1 shows simulation results with exponential data and models. As expected, the results
for dˆeff estimated by (4) are exact, whereas EHSSd (6) is a linear approximation that tends to
underestimate the number of events borrowed in these simulations.
Figure 1: Simulation results with exponential data and models. The panels are split by the hazard
ratio (HR) between experimental and control groups, and the diagonal dashed red lines have an
intercept of 0 and a slope of 1 and indicate agreement. 1,000 datasets were generated for each HR.
3.2 Weibull data
We also fit Cox models to simulated Weibull data, again using the survival package (Therneau,
2015) for R (R Core Team, 2019) to fit all models. The Weibull simulations were the same as
the exponential simulations with the addition of a shape parameter that was set to 1.15 for an
4
increasing hazard over time (see appendices for details). Of the 4,000 simulations, we deemed
1,239 estimates of dˆeff (obtained via (5)) to be unstable as diagnosed by ∂τˆ
2
ref(deff)/∂deff < exp(−3),
where the derivative at deff = dˆeff was approximated with a central finite difference. The root
finding algorithm failed for an additional 67 simulations, which we also considered unstable, for a
total of 1,306 unstable estimates.
The cutoff of ∂τˆ2ref(deff)/∂deff < exp(−3) was chosen to exclude highly implausible values in
this particular simulation. If this estimation procedure for dˆeff were used in practice, we would
recommend that a cutoff value be chosen prior to the interim analysis based on simulations specific
to the trial setting. If the derivative falls below the chosen a priori cutoff at interim, then we would
recommend using other methods to estimate dˆeff.
Figure 2 shows the results with unstable dˆeff removed but with the corresponding EHSSd es-
timates shown in the lower panels. In practice, we can use the derivative diagnostic to assess the
stability of dˆeff prior to interpreting results, but the same is not true of EHSSd, which is why we
retain all EHSSd estimates.
Figure 2: Simulation results with Weibull data and Cox model. The panels are split by the hazard
ratio (HR) between experimental and control groups and whether dˆeff was deemed stable. The
diagonal dashed red lines have an intercept of 0 and a slope of 1 and indicate agreement. dˆeff
results that were deemed unstable have been removed (1,306 removed), but the corresponding
EHSSd estimates are shown in lower panels. 1,000 datasets were generated for each HR.
Table 1 shows the empirical bias and standard deviation. The generalized estimate of dˆeff has
lower bias and standard deviation than the linear approximation when restricting to estimates for
which the root finding algorithm succeeded and ∂τˆ2ref(deff)/∂deff ≥ exp(−3), but as noted above,
this excludes a large proportion of the simulation results (32.7%). The full simulation results are
shown in Appendix C, which highlight the importance of using diagnostics prior to interpreting
results.
We also note that the linear approximation has higher standard deviation when the correspond-
ing dˆeff is unstable than when it is stable. This suggests that the diagnostic for dˆeff may be useful
even if another approach is ultimately used to obtain an estimate of the number of events effectively
borrowed.
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Table 1: Empirical bias and standard deviation from Weibull simulations. Unstable dˆeff were
removed but results for the corresponding EHSSd are shown in the rows labeled as “Unstable.”
dˆeff Stability HR Method # Sims Bias St. Dev
Stable 0.4 dˆeff (5) 301 0.876 2.28
Stable 0.4 EHSSd (6) 301 -7.27 2.82
Stable 0.6 dˆeff (5) 631 0.687 2.01
Stable 0.6 EHSSd (6) 631 -6.71 3.00
Stable 0.8 dˆeff (5) 836 0.571 2.50
Stable 0.8 EHSSd (6) 836 -5.82 3.39
Stable 1 dˆeff (5) 926 0.171 2.39
Stable 1 EHSSd (6) 926 -4.64 3.27
Unstable 0.4 EHSSd (6) 699 -12.0 6.09
Unstable 0.6 EHSSd (6) 369 -9.78 5.56
Unstable 0.8 EHSSd (6) 164 -8.49 5.00
Unstable 1 EHSSd (6) 74 -6.45 5.11
4 Discussion
Adaptive trial designs using external data have the promise to improve the efficiency and feasibility
of randomized controlled trials in settings where enrollment is challenging. The amount of data
effectively borrowed from external data is a key piece of input to calculate changes to the ran-
domization ratio, but may be challenging to quantify accurately outside of unadjusted exponential
models.
We hypothesize that this difficulty is because in general, the estimated precision is not solely
a function of the number of events. For example, in general the precision of a Cox regression is a
function of both the number and relative timing of events across groups, as seen by inspecting the
form of the information matrix. Consequently, up-weighting the trial controls to effectively create
more events can only represent a narrow range of potentially observable outcomes had additional
controls been enrolled in the trial, particularly with small sample sizes. As seen in Figure 2
and Table 1, diagnostics for our generalized solution (5) can also identify situations in which the
standard linear approximation has higher bias and variance, suggesting that some scenarios may
be inherently challenging.
Morita et al. (2008) minimized the distance between two information matrices to estimate the
effective sample size of a Bayesian prior distribution. As we demonstrate, minimizing the distance
between two variances (or equivalently, two precisions) can also be used to determine effective
sample size outside of a Bayesian context, and can be applied to frequentist and semi-parametric
models such as Cox regression. This may help to enable the use of a wider variety of methods in
adaptive hybrid controlled trials.
5 Conclusion
For unadjusted exponential models, we recommend using the exact solution given by (4) to estimate
the number of external events effectively borrowed. For all other situations, we recommend con-
ducting trial specific simulations to assess the behavior of different methods, such as the standard
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linear approximation and proposed generalized solution. The simulations can help guide the choice
of method and diagnostic, highlight limitations, and improve the interpretation of the estimated
amount of borrowed information.
Supplementary material
R code for the simulations is available at
https://github.com/flatironhealth/code-for-enee-paper.
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Appendices
A Generalized solution
As noted in the Section 2.2, for a given case weight w, the effective number of additional events
in the control arm of the trial is deff = wdC − dC = dC(w − 1). We also have the constraint that
w = deff/dC + 1 > 0, which implies deff > −dC .
For a given deff, we set w = deff/dC + 1 and fit the reference model to the trial data where
patient i gets weight
wi =
{
w if patient i is in control arm
1 if patient i is in experimental arm.
Let ψ(deff) = τˆ
2
ref(deff) − τˆ2hyb. We numerically solve for dˆeff such that ψ(dˆeff) = 0. In the
simulations, we searched for a solution over the interval (−dC+0.001, 1000). We then approximated
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∂τˆ2ref(deff)/∂deff at deff = dˆeff by
∂τˆ2ref(deff)
∂deff
∣∣∣∣
deff=dˆeff
≈ τˆ
2
ref(dˆeff + )− τˆ2ref(dˆeff − )
2
.
In the simulations, we set  = 0.0001.
B Details of simulations
Exponential data: For each of four hazard ratios between experimental and control groups (0.4,
0.6, 0.8, and 1), we conducted 1,000 simulations for a total of 4,000 simulated datasets. For each
simulation, we randomly selected the size of the trial uniformly between 60 and 100, and a censoring
probability uniformly between 0.05 and 0.1. We triggered the interim after 33% of patients had an
observed event (censoring all events occurring after this time). We also required that at least 10
event had occurred in each arm before triggering the interim to prevent pathological simulations.
We generated trial data assuming a linear enrollment of 2 patients per month with a 1:1 ran-
domization ratio and exponential outcomes with a hazard rate of 1/12 in the control arm (mean
of 12 months-to-event). We then randomly selected the number of external patients uniformly be-
tween 10 and the number of control patients in the trial who had enrolled by the time the interim
was conducted, and simulated exponential outcomes with the same hazard and censoring rate as
the trial controls. External patients were censored at the max follow-up time in the trial to ensure
comparability of endpoints.
Weibull data: For the Weibull simulations, we followed the same approach as above and set
the shape parameter to 1.15 for an increasing hazard over time. For the Weibull simulations, the
expected censoring rate was not exactly as specified.
C Full results of Weibull simulation
As noted in Section 3.2, 1,306 simulations had unstable dˆeff estimates (1,239 had small ∂τˆ
2
ref(deff)/∂deff
and 67 had solutions outside of (−dC + 0.001, 1000)). In practice, we would recommend defining a
cutoff for ∂τˆ2ref(deff)/∂deff a priori based on simulations tailored to the trial at hand, and only using
the results of the generalized solution if ∂τˆ2ref(deff)/∂deff is larger than the predefined threshold. It
could also be helpful to set a reasonable upper bound over which to search with the root-finding
algorithm. To provide insight into the problems that could arise if diagnostics and reasonable
upper limits are not taken into account, Figure 3 shows all simulation results. As can be seen in
Figure 3, in these simulation scenarios the instability can lead to enormous errors, highlighting the
importance of using diagnostics prior to interpreting results.
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Figure 3: Simulation results with Weibull data and Cox models without removing unstable results.
The panels are split by the hazard ratio (HR) between experimental and control groups and the
diagonal dashed red lines have an intercept of 0 and a slope of 1 and indicate agreement. 1,000
datasets were generated for each HR.
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